Zhejiang Orient Gene Biotech (688298.SS) Earnings Analysis
Zhejiang Orient Gene Biotech (688298.SS) has no confirmed upcoming earnings date. Trailing P/E -6.48.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 688298.SS next report earnings?
No confirmed upcoming earnings date is currently scheduled for 688298.SS. This page updates as the calendar is published.
688298.SS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-12-31 | -1.85178 CNY | n/a | n/a | n/a |
| 2025-09-29 | -0.25881 CNY | n/a | n/a | n/a |
| 2025-03-31 | -0.57 CNY | n/a | n/a | n/a |
| 2024-08-29 | -0.42591 CNY | n/a | n/a | n/a |
688298.SS valuation and analyst view
| Trailing P/E | -6.48 |
|---|---|
| Trailing EPS | -2.83009 CNY |
| Price / book | 0.60 |
| Dividend yield | 0.00% |
| Market cap | 3.73B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Zhejiang Orient Gene Biotech (688298.SS)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 688298.SS. This page updates as the calendar is published.
Did 688298.SS beat earnings last quarter?
Consensus estimate data was not available for 688298.SS's 2025-12-31 report.
What is 688298.SS's current P/E ratio and EPS?
688298.SS trades at a trailing P/E of -6.48 on trailing EPS of -2.8300924008724255 CNY.
What do analysts rate 688298.SS?
688298.SS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.